Reported Earlier, Verastem Oncology Prices $55M Public Offering Of 13,333,334 Common Stock, Warrants And Pre-Funded Warrants
Portfolio Pulse from Benzinga Newsdesk
Verastem Oncology (NASDAQ:VSTM) has announced the pricing of a $55 million public offering, which includes 13,333,334 shares of common stock and accompanying warrants, as well as pre-funded warrants. The offering price is $3.00 per share and $2.999 per pre-funded warrant, with warrants exercisable at $3.50 per share.
July 24, 2024 | 6:45 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Verastem Oncology has priced a $55 million public offering, including common stock and warrants. The offering price is $3.00 per share, with warrants exercisable at $3.50 per share.
The public offering will likely dilute existing shares, which could put downward pressure on the stock price in the short term. However, the raised capital could be beneficial for long-term growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100